Centrovas uses AI-powered patient-matching software to accelerate clinical trial enrollment. Their platform connects patients and clinics with relevant trials, aiming to improve access and speed up drug discovery.
Funding
Funding not disclosed
Founders
Product
Problem
Clinical trial recruitment is often slow and inefficient due to the manual labor required to extract and analyze patient data from electronic health records. This leads to delays in drug discovery and increased costs, hindering the development of new treatments.
Solution
Centrova offers an AI-powered patient-matching platform designed to accelerate clinical trial enrollment. The platform, called CrystalAI, automates the process of matching patients to relevant trials by analyzing existing data within provider and researcher systems. By streamlining recruitment and enrollment, Centrova aims to reduce the time and cost associated with clinical trials, ultimately accelerating drug discovery and improving patient access to effective treatments. The system is designed to be modular and customizable to fit specific site workflows.
Target Audience
Centrova primarily targets hospitals, pharmaceutical companies, researchers, and providers involved in clinical trials, particularly those focused on cancer and rare diseases.
Features
- AI-powered patient recruitment system
- Automated matching of patients to trials based on existing onsite data
- Customizable and modular design to fit unique site workflows
- Integration with electronic health records (prioritizing Epic)
- Adaptive analytics
- Automated case report forms
- Out-of-network patient matching
- Patient relationship management (PRM) tools
- Advanced patient communication tools